We are live on ! Find out more
AQR Capital Management

AQR Capital Management Portfolio holdings

AUM $218B
1-Year Est. Return 29.41%
This Fund
S&P 500
This Quarter Est. Return
+8.88%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$88B
AUM Growth
+$3.05B
Cap. Flow
-$3.28B
Cap. Flow %
-3.73%
Top 10 Hldgs %
12.89%
Holding
2,253
New
146
Increased
815
Reduced
1,092
Closed
142

Top Buys

Rank Stock Value
1
HUM icon
Humana
HUM
+$267M
2
HD icon
Home Depot
HD
+$252M
3
NOC icon
Northrop Grumman
NOC
+$221M
4
GILD icon
Gilead Sciences
GILD
+$175M
5
DG icon
Dollar General
DG
+$137M

Top Sells

Rank Stock Value
1
HPQ icon
HP
HPQ
+$287M
2
TWTR
Twitter, Inc.
TWTR
+$278M
3
BIIB icon
Biogen
BIIB
+$244M
4
IWV icon
iShares Russell 3000 ETF
IWV
+$198M
5
EXC icon
Exelon
EXC
+$185M

Sector Composition

Rank Sector Weight
1 Technology 20.05%
2 Financials 14.3%
3 Healthcare 13.64%
4 Consumer Discretionary 13.24%
5 Industrials 11.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VATE icon
2101
INNOVATE Corp
VATE
$165M
$63K ﹤0.01%
2,886
PVLA
2102
Palvella Therapeutics
PVLA
$2.27B
$62K ﹤0.01%
+214
New +$59.3K
GTE icon
2103
Gran Tierra Energy
GTE
$317M
$50K ﹤0.01%
3,901
CBAY
2104
DELISTED
Cymabay Therapeutics
CBAY
$36K ﹤0.01%
+18,335
New +$68.9K
IPI icon
2105
Intrepid Potash
IPI
$469M
$28K ﹤0.01%
1,028
-3,211
-76% -$87.2K
FTSI
2106
DELISTED
FTS International, Inc. Common Stock
FTSI
$21K ﹤0.01%
987
-42,339
-98% -$1.14M
UEC icon
2107
Uranium Energy
UEC
$5.57B
$19K ﹤0.01%
20,939
ATHX
2108
DELISTED
Athersys, Inc. Common Stock
ATHX
$17K ﹤0.01%
559
PFIE
2109
DELISTED
Profire Energy, Inc
PFIE
$16K ﹤0.01%
11,285
-41,019
-78% -$67.1K
NE
2110
DELISTED
Noble Corporation
NE
$13K ﹤0.01%
+10,362
New +$12.4K
SMTA
2111
DELISTED
Spirit MTA REIT Common Shares of Beneficial Interest
SMTA
$12K ﹤0.01%
+15,539
New +$43.6K
ABEO icon
2112
Abeona Therapeutics
ABEO
$413M
-1,479
Closed -$84K
AIRG icon
2113
Airgain
AIRG
$72.4M
-19,518
Closed -$229K
ATEX icon
2114
Anterix
ATEX
$1.94B
-7,670
Closed -$278K
ATRA icon
2115
Atara Biotherapeutics
ATRA
$76.1M
-451
Closed -$159K
ATRC icon
2116
AtriCure
ATRC
$2.11B
-12,900
Closed -$322K
AXTI icon
2117
AXT Inc
AXTI
$5.8B
-132,245
Closed -$471K
BAND
2118
Bandwidth Inc
BAND
$1.61B
-39,629
Closed -$2.58M
BATRK icon
2119
Atlanta Braves Holdings Series B
BATRK
$3.21B
-7,940
Closed -$220K
BOX icon
2120
Box
BOX
$4.6B
-208,972
Closed -$3.46M
CALM icon
2121
Cal-Maine
CALM
$3.99B
-63,409
Closed -$2.53M
CARG icon
2122
CarGurus
CARG
$3.47B
-7,464
Closed -$231K
CDXS icon
2123
Codexis
CDXS
$158M
-26,321
Closed -$361K
CIVI
2124
DELISTED
Civitas Resources
CIVI
-15,964
Closed -$357K
CLB icon
2125
Core Laboratories
CLB
$521M
-4,398
Closed -$202K

Similar funds

AQR Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, AQR Capital Management held 2,253 positions worth $88B, up 3.6% from $84.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

AQR Capital Management withdrew a net $3.28B in Q4 2019, closing 142 positions and reducing 1,092 holdings. Its most notable exit was iShares Russell 3000 ETF, an estimated $198M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

Against the trend, AQR Capital Management opened a new position in DaVita worth $31.1M.

  • AQR Capital Management's largest Q4 2019 buy was DaVita: 417,883 shares worth $31.1M.
  • AQR Capital Management added most to Humana in Q4 2019, an estimated $267M increase.
  • AQR Capital Management's biggest Q4 2019 reduction was HP, cutting an estimated $287M.
  • AQR Capital Management fully exited iShares Russell 3000 ETF in Q4 2019, selling an estimated $198M.
  • AQR Capital Management's ten largest holdings make up 13% of its $88B portfolio in Q4 2019.
  • AQR Capital Management opened 146 new positions and closed 142 in Q4 2019.
  • AQR Capital Management's portfolio value rose 3.6% quarter-over-quarter to $88B.

Based on AQR Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.